We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Product recall for Eco White Carton Shaving Kit presenting a serious microbiological risk as it contains Burkholderia, which may present a risk to vulnerable people in critical care areas & those with cystic fibrosis.
The Commission on Human Medicines (CHM) has concluded that the risk of vCJD cases arising from the use of UK plasma for the manufacture of immunoglobulin medicinal products would be negligible.
Information for wholesale dealer licence holders about the medicines put on the UK market for UK patients that they cannot export or hoard.
This is a review of entitlement to Industrial Injuries Disablement Benefit for people with latex anaphylaxis.
Paper prepared by academics at New York University (NYU) on COVID-19 and hospitalisation.
Employment Tribunal decision.
Healthcare professionals prescribing fluoroquinolone antibiotics (ciprofloxacin, delafloxacin, levofloxacin, moxifloxacin, ofloxacin) are reminded to be alert to the risk of psychiatric reactions, including depression and psychotic reactions, which may potentially lead to thoughts of suicide or suicide attempts. Healthcare professionals are...
Upper Tribunal Administrative Appeals Chamber decision by Judge Citron on 14 June 2024
Guidance on acetic acid (also known as ethanoic acid) for use in responding to chemical incidents.
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices, and a recent National Patient Safety Alert asking organisations to put a plan in place to implement new regulatory measures for valproate.
How to show MHRA you're meeting good clinical practice (GCP) standards and what to expect from an inspection.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).